Taken together with our previous results (Tomimoto et al., 2004), these data indicate that PACAP universally and persistently inhibits the increase of islet density from the early postnatal period in type II diabetes models. The gene discussed is ADCYAP1; the disease is type 2 diabetes mellitus.